# Selank vs Semax: Comparing the Research

> Selank vs Semax: two Russian research peptides with different jobs. Selank is a tuftsin-analogue anxiolytic; Semax is an ACTH-derived nootropic. How their mechanisms and findings compare, cited.

Two Russian research peptides, two different design goals — set side by side on mechanism, evidence, and what each is actually studied for.

## The short version

**Selank vs Semax** is a comparison of two different peptides that get grouped together because both came out of Russian peptide research and both are studied for the brain. They are not the same molecule and should never be treated as interchangeable. The simplest way to hold them apart: Selank is built from an immune peptide (tuftsin) and is studied mainly as an anti-anxiety (anxiolytic) compound that calms without sedation. Semax is a different peptide derived from a fragment of the hormone ACTH and is studied mainly as a focus-and-recovery (nootropic, neuroprotective) compound. People sometimes look at the two together because the reported feel is complementary — Selank for calm, Semax for drive — but the research records, mechanisms, and origins are distinct. This page sticks to what Selank's own literature supports; it is not a claim that either treats any condition.

## Different molecules, different origins

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro), a stabilized analogue of the endogenous immune tetrapeptide tuftsin, developed by the Institute of Molecular Genetics RAS with the Zakusov Institute of Pharmacology [6]. Semax is a separate synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). They share a research lineage and an intranasal delivery tradition, but they are structurally unrelated peptides with different parent molecules. Conflating them — a common mistake online — misstates both. Everything this site documents is about Selank's literature; Semax is referenced here only to draw the contrast.

## Different primary effects in the research

The mechanisms point in different directions. Selank's anxiolytic activity centers on the GABA system, where it acts as a positive allosteric modulator of GABA receptor binding [1], paired with enkephalinase inhibition that stabilizes the body's own enkephalins [2]. That combination is why its signature research and community signal is calm without sedation. Selank also shows nootropic effects — it optimized a conditioned active-avoidance reflex in rats [8] and raised hippocampal BDNF [3] — but its center of gravity is anxiety. Semax, by contrast, is studied principally as a nootropic and neuroprotective agent. So the cleanest framing of Selank vs Semax is overlapping but distinct: both touch cognition, but Selank leads with calm and Semax leads with cognition and neuroprotection.

## Evidence base — the shared caveat

Both peptides carry the same structural limitation, and it is the most important thing in any honest comparison. The Selank evidence base is overwhelmingly from Russian research groups, with many papers in Russian-language journals carrying English abstracts only, and limited independent Western replication [16]. Selank is not approved by the FDA or EMA and is sold only as a research chemical. The same single-region, thin-by-Western-standards caveat applies to Semax. Neither is a substitute for evidence-based care, and neither should be described as a treatment. The comparison is between two research programs, not two medicines.

## Should they be studied together?

Because the reported profiles look complementary — Selank for calm, Semax for focus — they are frequently discussed as a pair. The honest research answer is that the published Selank literature does not establish a validated Selank-plus-Semax protocol; what exists is mechanism and small single-region clinical data on each peptide separately. The one combination finding in Selank's own record involves diazepam, not Semax: a rat study found Selank plus diazepam most effective at reducing stress-induced anxiety [7], which speaks to GABAergic interaction rather than to stacking the two peptides. Any pairing of Selank and Semax sits outside what the cited evidence supports, and this site makes no usage recommendation.

---

A hopeful read of the Selank research, told honestly — editorial summaries of the published science, never medical advice.